LeMaitre Vascular Set to Engage Investors
LeMaitre Vascular, Inc. (NASDAQ: LMAT) is gearing up for an exciting December as it announces participation in two significant investor conferences. These events offer a great opportunity for investors to connect with the company and learn more about its innovative contributions to the field of vascular health.
Investors Can Look Forward to Key Presentations
David Roberts, the President of LeMaitre Vascular, will be making a notable appearance at the Piper Sandler 36th Annual Healthcare Conference. This event will be held on a Tuesday in early December at the Lotte New York Palace, located in New York City. During this presentation, Roberts is slated to discuss LeMaitre's recent advancements and future directions in vascular technologies, scheduled for 3:30 PM EST.
Additionally, Roberts will also present at the Stifel "MedTech Madness" West Coast Bus Tour. This prestigious event occurs at the elegant Rosewood Sand Hill in Menlo Park, California, on a Thursday in December, and his presentation is scheduled for 11:45 AM PST. This engagement is an excellent platform for Roberts to highlight the company’s commitment to improving outcomes for patients suffering from peripheral vascular disease.
Understanding LeMaitre Vascular's Role in Healthcare
LeMaitre Vascular is dedicated to enhancing patient care with its wide range of devices, implants, and services designed explicitly for the treatment of peripheral vascular disease. This condition affects a staggering demographic worldwide, impacting over 200 million individuals.
The focus of the company is on developing, manufacturing, and marketing both disposable and implantable vascular devices that serve the unique needs of vascular surgeons. With a commitment to innovation, LeMaitre is continually seeking new ways to support healthcare professionals and their patients alike.
Commitment to Quality and Innovation
As a trusted name in the medical industry, LeMaitre maintains high standards of quality in its product offerings. By focusing on the evolving needs of healthcare and technology, the company is poised to lead the way in vascular care. With their impressive lineup of products, including cutting-edge technologies for both diagnostics and treatment, they remain a frontrunner in this essential healthcare sector.
How to Connect with LeMaitre
Investors or those interested in learning more about LeMaitre Vascular's innovations can find additional information on their official website. The site provides details on their available products, corporate news, and upcoming events. LeMaitre is also aware of the significance of open communication and encourages inquiries related to business development and investor relations.
For direct contact, interested parties can reach out to Gregory Manker, the Director of Business Development & Investor Relations at LeMaitre Vascular, Inc. Manker is available for consultations and ready to assist with any inquiries.
Frequently Asked Questions
What is the main focus of LeMaitre Vascular?
The primary focus of LeMaitre Vascular is to provide innovative devices and services for the treatment of peripheral vascular disease.
Who will be presenting at the upcoming conferences?
David Roberts, the President of LeMaitre Vascular, will be presenting at the upcoming investor conferences.
When will the Piper Sandler conference take place?
The Piper Sandler conference is set to take place on a Tuesday in December.
How can I learn more about LeMaitre's products?
More information about LeMaitre's products and corporate updates can be found on their official website.
Who should I contact for investor relations inquiries?
Gregory Manker is the contact person for business development and investor relations at LeMaitre Vascular, Inc.
